2004-131 Resolution - Laserfiche WebLink

Home Browse Search

33.3 EMPLOYEE TESTING Employees shall not be subjected to random medica( testing involving urine or blood analysis or other similar or related tests for the purpose of discovering possible drug or alcohol abuse. If, however, objective evidence exists establishing reasonable suspicion to believe an Employee's work performance is impaired due to drug or alcohol abuse, the Employer will require the Employee to undergo a medical test consistent with the conditions as set forth in this Policy. 33.4 SAMPLE COLLECTION The collection and testing of the samples shall be performed only by a laboratory and by a physician or health care professional qualified and authorized to administer and determine the meaning of any test results. The laboratory performing the test shall be one that is certified by the National Institute of Drug Abuse (NIDA). The laboratory chosen must be agreed to between the Association and the Employer. The laboratory used shall also be one whose procedures are periodically tested by NIDA where they analyze unknown samples sent to an independent party. The results of Employee tests shatl be made available to the Medical Review Physician. Collection of blood or urine samples shall be conducted in a manner which provides the highest degree of security for the sample and freedom from adutteration. Recognized strict chain of custody procedures must be followed for all samples as set by NIDA. The Association and the Employer agtee that security of the biological urine and blood samples is absolutely necessary, therefore, the Employer agrees that if the security of the sample is compromised in any way, any positive test shall be invalid and may not be used for any purpose. Blood or urine samples will be submitted as per NIDA Standards. Employees have the right for Association or legal counsel representatives to be present during the submission of the sample. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test resutt. AIl samples must be stored in a scientific acceptable preserved manner as established by NIDA. All positive confirmed samples and related paperwork must be retained by the laboratory for at least six months or for the duration of any grievance disciplinary action or legal proceedings, whichever is longer. At the conc[usion of this period, the paperwork and specimen shall be destroyed. Tests shal( be conducted in a manner to ensure that an Employee's (egal drug use and diet does not affect the test results: 33.5 DRUG TESTING The laboratory shail test only for substances and within the limits for tite initial and confirmation test as provided within NIDA standards. The initial test shall use an immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The following 46